Online citations, reference lists, and bibliographies.
← Back to Search

Pulmonary Toxicity And Kinetic Study Of Cy5.5-conjugated Superparamagnetic Iron Oxide Nanoparticles By Optical Imaging.

W. Cho, Minjung Cho, S. R. Kim, M. Choi, J. Y. Lee, B. S. Han, S. Park, M. Yu, S. Jon, J. Jeong
Published 2009 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Recent advances in the development of nanotechnology and devices now make it possible to accurately deliver drugs or genes to the lung. Magnetic nanoparticles can be used as contrast agents, thermal therapy for cancer, and be made to concentrate to target sites through an external magnetic field. However, these advantages may also become problematic when taking into account safety and toxicological factors. This study demonstrated the pulmonary toxicity and kinetic profile of anti-biofouling polymer coated, Cy5.5-conjugated thermally cross-linked superparamagnetic iron oxide nanoparticles (TCL-SPION) by optical imaging. Negatively charged, 36 nm-sized, Cy5.5-conjugated TCL-SPION was prepared for optical imaging probe. Cy5.5-conjugated TCL-SPION was intratracheally instilled into the lung by a non-surgical method. Cy5.5-conjugated TCL-SPION slightly induced pulmonary inflammation. The instilled nanoparticles were distributed mainly in the lung and excreted in the urine via glomerular filtration. Urinary excretion was peaked at 3 h after instillation. No toxicity was found under the concentration of 1.8 mg/kg and the half-lives of nanoparticles in the lung and urine were estimated to be about 14.4+/-0.54 h and 24.7+/-1.02 h, respectively. Although further studies are required, our results showed that Cy5.5-conjugated TCL-SPION can be a good candidate for use in pulmonary delivery vehicles and diagnostic probes.
This paper references
10.1016/S0378-5173(99)00295-1
Proteolytic enzymes as a limitation for pulmonary absorption of insulin: in vitro and in vivo investigations.
Z. Shen (1999)
10.1021/JA072210I
Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo.
Haerim Lee (2007)
10.1016/J.YMTHE.2003.07.007
Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo.
A. Ziady (2003)
10.1016/S0041-008X(02)00024-8
Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis.
A. Nemmar (2003)
10.1539/joh.50.1
Body Distribution of Inhaled Fluorescent Magnetic Nanoparticles in the Mice
Jung-Taek Kwon (2008)
10.1023/B:PHAM.0000019302.26097.cc
3H Dendrimer Nanoparticle Organ/Tumor Distribution
Shraddha S. Nigavekar (2004)
10.1006/TAAP.1996.0045
Pulmonary inflammatory, chemokine, and mutagenic responses in rats after subchronic inhalation of carbon black.
K. Driscoll (1996)
10.1093/TOXSCI/KFI327
Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology.
A. Elder (2005)
10.1073/pnas.182233999
Trojan particles: Large porous carriers of nanoparticles for drug delivery
N. Tsapis (2002)
10.1016/S0002-9440(10)63588-2
Regulatory effects of iNOS on acute lung inflammatory responses in mice.
C. Speyer (2003)
10.1002/anie.200800857
Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo.
M. Yu (2008)
10.1165/AJRCMB.10.2.8110470
Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation.
Z. Xing (1994)
10.1021/JA061529K
Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging.
Haerim Lee (2006)
Locoregional cancer treatment with magnetic drug targeting.
C. Alexiou (2000)
10.1016/J.TOXLET.2007.09.008
Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles.
W. Cho (2007)
10.1046/j.1365-2796.1996.502836000.x
Intrapulmonary administration of insulin to healthy volunteers
J. Jendle (1996)
Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine.
D. O'hagan (1990)
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.
A. Lübbe (1996)
Tumor necrosis factor α regulates in vivo intrapulmonary expression of ICAM-1
M. Mulligan (1993)
10.1016/S1074-7613(00)80334-9
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.
M. Romano (1997)
10.1016/j.ijpharm.2007.12.041
Histological examination of PLGA nanospheres for intratracheal drug administration.
Kaori Hara (2008)
10.1126/SCIENCE.276.5320.1868
Large porous particles for pulmonary drug delivery.
D. Edwards (1997)
10.1073/PNAS.0509009103
Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers.
R. Singh (2006)
10.1021/MP0500014
Iron oxide nanoparticles for sustained delivery of anticancer agents.
Tapan Jain (2005)
10.1093/TOXSCI/KFJ027
Toxicity and tissue distribution of magnetic nanoparticles in mice.
J. Kim (2006)
10.1289/ehp.10290
Persistent Tissue Kinetics and Redistribution of Nanoparticles, Quantum Dot 705, in Mice: ICP-MS Quantitative Assessment
R. Yang (2007)
10.1615/CRITREVTHERDRUGCARRIERSYST.V12.I2-3.20
Delivery of biotherapeutics by inhalation aerosol.
R. Niven (1995)
10.4049/jimmunol.164.5.2650
Role of CC Chemokines (Macrophage Inflammatory Protein-1β, Monocyte Chemoattractant Protein-1, RANTES) in Acute Lung Injury in Rats1
N. Bless (2000)
10.1002/SMLL.200600009
Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery.
N. Kohler (2006)
10.1016/0378-4274(96)03712-5
The carcinogenic potency of carbon particles with and without PAH after repeated intratracheal administration in the rat.
C. Dasenbrock (1996)
10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q
Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers.
J. Roberts (1996)
10.1093/TOXSCI/KFM243
Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles.
G. Baker (2008)
10.1152/AJPCELL.00467.2004
Regulatory effects of estrogen on acute lung inflammation in mice.
C. Speyer (2005)
10.1016/S0041-008X(03)00192-3
Effect of polystyrene particles on lung microvascular permeability in isolated perfused rabbit lungs: role of size and surface properties.
J. Hamoir (2003)
10.1164/AJRCCM.164.9.2101036
Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster.
A. Nemmar (2001)
10.1513/PATS.200409-049TA
The lungs as a portal of entry for systemic drug delivery.
John S. Patton (2004)
10.1016/j.taap.2008.12.023
Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles.
W. Cho (2009)
10.1016/S0958-1669(00)00202-0
Emerging protein delivery methods.
J. Cleland (2001)
10.1038/nbt1340
Renal clearance of quantum dots
H. Choi (2007)
10.1002/JBM.A.30901
The application of Fe3O4 nanoparticles in cancer research: a new strategy to inhibit drug resistance.
X. Wang (2007)
10.1007/s00249-006-0042-1
Targeting cancer cells: magnetic nanoparticles as drug carriers
C. Alexiou (2006)



This paper is referenced by
Molecular imaging and gene therapy in experimental arthritis: a luminescent future for targeted therapy?
Eline A. Vermeij (2016)
10.1111/j.1469-0691.2012.03809.x
Super-paramagnetic iron oxide nanoparticles for use in extrapulmonary tuberculosis diagnosis.
C. Lee (2012)
10.4149/GPB_2016004
The tolerability of dextran-coated iron oxide nanoparticles during in vivo observation of the rats.
C. Popa (2016)
10.1002/mrm.24768
In vivo imaging of islet transplantation using PLGA nanoparticles containing iron oxide and indocyanine green
J. Hwang (2014)
10.1016/j.imlet.2013.11.019
Interactive threats of nanoparticles to the biological system.
Ruchi Roy (2014)
Toksykologia współczesna nanomateriałów magnetycznych
M. Cywińska (2012)
10.1371/journal.pone.0126687
The In-Vivo Use of Superparamagnetic Iron Oxide Nanoparticles to Detect Inflammation Elicits a Cytokine Response but Does Not Aggravate Experimental Arthritis
E. Vermeij (2015)
10.1016/j.taap.2010.02.013
Size-dependent tissue kinetics of PEG-coated gold nanoparticles.
W. Cho (2010)
10.2147/IJN.S25588
A role of cellular glutathione in the differential effects of iron oxide nanoparticles on antigen-specific T cell cytokine expression
C. Shen (2011)
10.1186/1743-8977-10-46
Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells
Hsin-Ying Wu (2013)
10.3390/nano8090634
Health Concerns of Various Nanoparticles: A Review of Their in Vitro and in Vivo Toxicity
Marziyeh Ajdary (2018)
10.1016/j.acra.2010.10.017
TCL-SPION-enhanced MRI for the detection of lymph node metastasis in murine experimental model.
S. Lim (2011)
10.2147/IJN.S83068
Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo
E. Fröhlich (2015)
TOKSYKOLOGIA WSPÓŁCZESNA NANOMATERIAŁÓW MAGNETYCZNYCH MODERN TOXICOLOGY OF MAGNETIC NANOMATERIALS
Adhvaryu Monika (2012)
10.1016/j.nano.2015.07.007
Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging.
Kengo Kanazaki (2015)
10.1088/1674-1056/22/12/127503
Toxicity of superparamagnetic iron oxide nanoparticles: Research strategies and implications for nanomedicine
Li Lei (2013)
10.2147/IJN.S21019
A single exposure to iron oxide nanoparticles attenuates antigen-specific antibody production and T-cell reactivity in ovalbumin-sensitized BALB/c mice
C. Shen (2011)
10.3390/ma3104842
Toxicity of Transition Metal Oxide Nanoparticles: Recent Insights from in vitro Studies
Y. Huang (2010)
10.2147/IJN.S29417
Evaluation of atherosclerotic lesions using dextran- and mannan–dextran-coated USPIO: MRI analysis and pathological findings
K. Tsuchiya (2012)
INHALABLE NANOCOMPOSITES AND ANTICANCER AGENTS FOR CANCER THERAPY
Nathanael A. Stocke (2015)
10.1109/TNANO.2013.2242089
Monitoring the Environmental Impact of TiO$_{\bf 2}$ Nanoparticles Using a Plant-Based Sensor Network
S. Lenaghan (2013)
10.1201/B15666-14
Analogies in the Adverse Immune Effects of Wear Particles, Environmental Particles, and Medicinal Nanoparticles
E. Fröhlich (2014)
10.1016/j.colsurfb.2014.06.064
Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells.
S. Dwivedi (2014)
10.1177/0960327112446515
Oxidative stress and inflammatory responses of rat following acute inhalation exposure to iron oxide nanoparticles
A. Srinivas (2012)
International Journal of Nanomedicine Dovepress
Chung-King Hsu ()
10.1016/j.cis.2013.06.007
Superparamagnetic iron oxide based nanoprobes for imaging and theranostics.
T. Lam (2013)
10.4103/bbrj.bbrj_54_17
Liposomes as potential nanocarriers for theranostic applications in chronic inflammatory lung diseases
Hande Suer (2017)
10.1016/j.tox.2010.06.002
Inflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in mice.
E. Park (2010)
10.1080/17435390.2016.1242797
Exposure to metal oxide nanoparticles administered at occupationally relevant doses induces pulmonary effects in mice
M. Présumé (2016)
10.1007/s11051-015-3216-x
PEGylation of superparamagnetic iron oxide nanoparticle for drug delivery applications with decreased toxicity: an in vivo study
Suma Prabhu (2015)
10.3109/03602532.2013.859688
The effects of engineered nanoparticles on pulmonary immune homeostasis
R. Mohamud (2014)
10.1007/s11051-014-2302-9
Biomarkers of nanomaterial exposure and effect: current status
I. Iavicoli (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar